Picton Mahoney Asset Management’s Verona Pharma VRNA Stock Holding History

Picton Mahoney Asset Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-245,000	Closed	-$26.1M	–	1363
2025 Q3	$26.1M	Buy	+245,000	New	+$25.6M	0.24%	74

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Picton Mahoney Asset Management's VRNA Position: Q4 2025 in Review

Picton Mahoney Asset Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 245,000 shares — an estimated $26.1M sold.

Picton Mahoney Asset Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $26.1M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Picton Mahoney Asset Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Picton Mahoney Asset Management sold 245,000 Verona Pharma shares in Q4 2025, an estimated $26.1M.
Picton Mahoney Asset Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Picton Mahoney Asset Management's Verona Pharma position peaked at $26.1M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.